<DOC>
	<DOCNO>NCT01243177</DOCNO>
	<brief_summary>Compare efficacy safety Lacosamide ( LCM ) Carbamazepine Controlled-Release ( CBZ-CR ) monotherapy newly recently newly diagnose subject primary efficacy endpoint 6-month seizure freedom . Noninferiority design show similar risk/benefit balance Lacosamide ( LCM ) Carbamazepine-CR ( CBZ-CR ) .</brief_summary>
	<brief_title>Trial Comparing Efficacy Safety Lacosamide ( LCM ) Carbamazepine Controlled-Release ( CBZ-CR ) ; Initial Monotherapy Epilepsy ; Subjects Aged 16 Older</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Subject able comply study requirement Subject 16 year old ( female ; male ) . Minors include country legally permit Subject newly recently diagnose Epilepsy experience partial onset seizure ( POS ) generalize tonicclonic seizure least 2 unprovoked seizure separate 48 hour 12 month precede Visit 1 least 1 seizure occur 3 month precede Visit 1 Subject Electroencephalogram ( EEG ) brain Computed Tomography ( CT ) scan Magnetic Resonance Imaging ( MRI ) exam brain within past 12 month . If EEG brain CT scan MRI exam perform prior Visit 1 , need complete result must available prior randomization Visit 2 Subject history presence seizures type partialonset ( IA , IB , IC clear focal origin ) generalize tonicclonic ( without clear focal origin ) seizures ( eg , myoclonic , absence ) Subject history presence seizures occur cluster pattern , define repeat seizure occur short period time ( ie , &lt; 20 minute ) without function regain 2 ictal event Subject history , clinical , Electroencephalogram ( EEG ) find suggestive Idiopathic Generalized Epilepsy ( IGE ) randomization Subject current previous diagnosis pseudoseizures , conversion disorder , nonepileptic ictal event could confuse seizure base expert opinion and/or EEG evidence Subject medical psychiatric condition Subject lifetime history suicide attempt ( include actual attempt , interrupt attempt , aborted attempt ) , suicidal ideation past 6 month indicate positive response ( Yes ) either Question 4 Question 5 ColumbiaSuicide Severity Rating Scale ( CSSRS ) Screening Subject receive treatment Phenobarbital Primidone within 28 day prior Visit 1 Subject take Benzodiazepines nonepilepsy indication Subject treat Epilepsy Antiepileptic Drug ( AED ) ( include Benzodiazepines ) last 6 month Visit . However , acute subacute seizure treatment accept maximum 2 week duration treatment stop least 3 day prior randomization Prior use Felbamate Vigabatrin allow Benzodiazepines rescue therapy Epilepsy may use needed time period , frequently per week Subject medical condition could reasonably expect interfere drug absorption , distribution , metabolism , excretion , history alcohol drug abuse within previous 2 year Asian ancestry test positive HLAB*1502 allele Asian ancestry test positive HLAA*3101 allele</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Lacosamide</keyword>
	<keyword>VimpatÂ®</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Monotherapy</keyword>
	<keyword>Velocity</keyword>
</DOC>